CLORHIDRAT DE METILFENIDAT G.L PHARMA 27mg prolonged-release tablets medication leaflet

N06BA04 methylphenidate • Nervous system | Psychostimulants, agents used for adhd and nootropics | Centrally acting sympathomimetics

Methylphenidate is a medication primarily used to treat attention deficit hyperactivity disorder (ADHD) and narcolepsy. It works by increasing dopamine and norepinephrine levels in the brain, which helps improve focus and reduce impulsivity.

The medication is available in immediate-release or extended-release tablet forms, and the dosage is adjusted based on the individual needs of the patient. Treatment with methylphenidate should be monitored by a doctor, as it may have side effects such as insomnia, loss of appetite, headaches, or increased blood pressure.

Methylphenidate is contraindicated in individuals with certain conditions, such as glaucoma, severe anxiety disorders, or a history of substance abuse. It is also important for patients to inform their doctor about any other medications they are taking to avoid drug interactions.

This medication should be used with caution in children, adolescents, and adults, and pregnant or breastfeeding women should consult their doctor before starting treatment.

General data about CLORHIDRAT DE METILFENIDAT G.L PHARMA 27mg

Substance: methylphenidate

Date of last drug list: 01-04-2026

Commercial code: W71759001

Concentration: 27mg

Pharmaceutical form: prolonged-release tablets

Quantity: 28

Product type: generic

Prescription restrictions: TAB2 - Medicines that are issued with a special prescription (narcotics) in yellow color.

Marketing authorisation

Manufacturer: LABORATORIOS LICONSA S.A. - SPANIA

Holder: G.L. PHARMA GMBH - AUSTRIA

Number: 16466/2026/01

Shelf life: 2 years

Concentrations available for methylphenidate

10mg, 18mg, 20mg, 27mg, 30mg, 36mg, 40mg, 54mg, 5mg

Other substances similar to methylphenidate